Related Experiment Video

Updated: Jun 18, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Oncoapoptosis: a novel molecular therapeutic for cancer treatment

John A Blaho1

  • 1Department of Microbiology, Mount Sinai School of Medicine, NY 10029-6574, USA. john.blaho@mssm.edu

IUBMB Life
|November 26, 2009
PubMed

Insights

A novel herpes simplex virus system triggers cancer cell death (apoptosis) specifically in tumor cells, offering a new therapeutic strategy. This oncoapoptosis approach targets cancer cells based on their p53 protein status, sparing healthy cells.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Many cancers resist conventional treatments like chemotherapy and radiation due to impaired apoptosis regulation.
  • This resistance leads to uncontrolled cancer cell proliferation, limiting therapeutic options.

Purpose of the Study:

  • To develop a novel therapeutic strategy targeting cancer cells resistant to conventional treatments.
  • To investigate the potential of a replication-defective herpes simplex virus for inducing cancer cell death (oncoapoptosis).

Main Methods:

  • Development of a replication-defective herpes simplex virus engineered to induce apoptosis.
  • Testing the virus's efficacy in targeting transformed human cancer cells.
  • Assessing the role of p53 protein status in determining susceptibility to virus-induced cell death.

Main Results:

  • The engineered virus, termed oncoapoptosis, selectively triggered apoptosis in transformed human cells.
  • Cancer cell susceptibility to oncoapoptosis was dependent on the p53 protein status.
  • Normal cells with functional p53 were resistant to oncoapoptotic killing, demonstrating targeted therapy.

Conclusions:

  • Non-replicating virus-induced apoptosis is a feasible molecular therapeutic approach for selectively killing human cancer cells.
  • This oncoapoptosis strategy holds significant promise for developing novel virus-based anticancer therapies.
  • Targeting cancer cells based on p53 status offers a precise approach to cancer treatment.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...